HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Endocrine-related cancer encompass a diverse group of malignancies that arise from the endocrine system, a complex network of glands responsible for hormone production and regulation. These cancers manifest when the normal regulatory mechanisms of the endocrine tissues are disrupted, leading to uncontrolled cell growth and the formation of tumors. The endocrine system includes glands such as the thyroid, pancreas, adrenal glands, and reproductive organs, making the types of endocrine-related cancers wide-ranging and influenced by hormonal factors. The intricate interplay between hormones and cellular functions underscores the complexity of these cancers.
Thyroid cancer, emerging from the thyroid gland, represents a common endocrine-related cancer. It includes differentiated forms such as papillary and follicular thyroid cancers, which are generally associated with favorable prognoses, especially when detected and treated early. Pancreatic cancer, affecting the pancreas with both endocrine and exocrine functions, includes pancreatic neuroendocrine tumors (PNETs), which can disrupt hormonal balance. Adrenal cancer, though rare, can be aggressive, with tumors affecting the adrenal glands and potentially leading to hormonal imbalances, causing symptoms like hypertension. Additionally, certain breast and ovarian cancers are influenced by hormonal factors, emphasizing the interconnectedness of the endocrine system and cancer development.
Endocrine-related cancers present unique challenges due to their diverse locations and hormonal influences. Diagnosing these cancers often involves a combination of imaging studies, hormone level assessments, and tissue biopsies. Treatment approaches may include surgery, radiation therapy, and targeted therapies to address specific molecular characteristics. Ongoing research in endocrine-related cancer aims to uncover the underlying genetic and molecular mechanisms, paving the way for more precise diagnostic tools and targeted therapies. Advances in understanding the intricate relationships between hormones and cancer cells hold
